Volume 116, Issue 3

Search all International Journal of Hematology articles

September 2022

Including PIH articles on Prevention and management of relapse after allogeneic hematopoietic cell transplantation in hematological malignancies

Filter by

Volume:

Sort by

Date published:

New to old Old to new

17 articles in this issue

Guest editorial: prophylaxis and treatment of relapse after allogeneic hematopoietic stem cell transplantation
Daigo Hashimoto
Progress in Hematology 11 July 2022 Pages: 307 - 308
Anti-programmed cell death-1 monoclonal antibody therapy before or after allogeneic hematopoietic cell transplantation for classic Hodgkin lymphoma: a literature review
Ayumu Ito
Sung-Won Kim
Takahiro Fukuda
Progress in Hematology 02 June 2022 Pages: 309 - 314
Efficacy and safety of CD19 CAR-T cell therapy for acute lymphoblastic leukemia patients relapsed after allogeneic hematopoietic stem cell transplantation
Xing-yu Cao
Jing-jing Li
Kai-yan Liu
Progress in Hematology 23 June 2022 Pages: 315 - 329
Relapse after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia: an overview of prevention and treatment
Firas Kreidieh
Iman Abou Dalle
Ali Bazarbachi
Progress in Hematology 16 July 2022 Pages: 330 - 340
FLT3-inhibitor therapy for prevention and treatment of relapse after allogeneic hematopoietic cell transplantation
Francesca Biavasco
Robert Zeiser
Progress in Hematology Open access 23 April 2022 Pages: 341 - 350
FLT3-targeted treatment for acute myeloid leukemia
Yasuyuki Arai
SungGi Chi
Masamitsu Yanada
Review Article 09 May 2022 Pages: 351 - 363
Peripartum management of hereditary thrombophilia: results of primary surveillance in Japan
Takao Kobayashi
Kazuko Sugiura
Eriko Morishita
Original Article 12 May 2022 Pages: 364 - 371
Hexokinase II expression as a prognostic marker in diffuse large B-cell lymphoma: pre- and post-rituximab era
Jia Jin
Ailing Gui
Qunling Zhang
Original Article 10 May 2022 Pages: 372 - 380
IBRORS-MCL study: a Spanish retrospective and observational study of relapsed/refractory mantle-cell lymphoma treated with ibrutinib in routine clinical practice
Juan-Manuel Sancho
Ana Marín-Niebla
Eva Rubio-Azpeitia
Original Article Open access 13 May 2022 Pages: 381 - 392
Propensity score matching/reweighting analysis comparing autologous and allogeneic stem cell transplantation for B-lineage acute lymphoblastic leukemia
Shuichi Mizuta
Tomotaka Ugai
Shinichi Kako
Original Article 10 May 2022 Pages: 393 - 400
Favorable outcomes of allogeneic hematopoietic stem cell transplantation with fludarabine–bendamustine conditioning and posttransplantation cyclophosphamide in classical Hodgkin lymphoma
Anastasia Beynarovich
Kirill Lepik
Boris Afanasyev
Original Article 05 May 2022 Pages: 401 - 410
MEdical Database AnaLysIS of Japanese multiple myeloma patienTs with apheresis #2 (MEDALIST-2): the impact of plerixafor use on costs and healthcare resources during mobilization and stem cell transplantation
Shinsuke Iida
Tadao Ishida
Takanori Teshima
Original Article 13 May 2022 Pages: 411 - 422
Longitudinal profiling of anti-factor VIII antibodies in Japanese patients with congenital hemophilia A during factor VIII replacement and immune-tolerance induction therapy
Takuji Yoshimura
Shoko Furukawa
Keiji Nogami
Original Article 03 May 2022 Pages: 423 - 433
A retrospective survey of patients who discontinued participation in the JPLSG HLH-2004 clinical trial
Rintaro Ono
Kenichi Sakamoto
on behalf of The HLH/LCH committee members of the Japan Children’s Cancer Group
Original Article 06 May 2022 Pages: 434 - 441
Secondary chronic myeloid leukemia in a patient with CALR and ASXL1-mutated primary myelofibrosis
Patryk Sobieralski
Maria Bieniaszewska
Jan Maciej Zaucha
Case Report 16 April 2022 Pages: 442 - 445
Discordant lymphomas of classic Hodgkin lymphoma and peripheral T-cell lymphoma following dupilumab treatment for atopic dermatitis
Kumi Nakazaki
Mina Yoshida
Mineo Kurokawa
Case Report 30 March 2022 Pages: 446 - 452
Feasibility of ovarian stimulation for fertility preservation during and after blinatumomab treatment for Ph-negative B-cell acute lymphoblastic leukemia
Yusuke Tashiro
Junya Kanda
Akifumi Takaori-Kondo
Case Report 14 March 2022 Pages: 453 - 458

Volume 116, Issue 3

Search

Navigation